Clinical Trial Environmental Impact
CMC Ontology
Data FAIRy Bioassay Annotation
Global Substance Registration System
IDMP Ontology
In Vitro NAM Data Standards
In Vitro Pharmacology
Large Language Models in Life Sciences
NLP Use Case Database
Pharma General Ontology
Pharmacovigilance Systems and Processes Standards
Social Media Real World Evidence
Current Projects
Delivered Projects
AI / ML
Change Management
CSCS
Data Governance
FAIR
Future Labs Evolution
Microbiome-Mediated Drug Metabolism Database
Quantum Computing
UXLS
Current Communities
Delivered Communities
Delivered Projects and Communities
New Ideas
Username or Email Address
Password
Remember Me
Webinar
The Center for Expanded Data Annotation and Retrieval (CEDAR) has the goal of enhancing the authoring of experimental metadata to make online datasets more useful to the scientific community.inar.
In this webinar Dr Henriette Harmse from EMBL-EBI presents how they are using their ontology services at EMBL-EBI to scale up the annotation of data and deliver added value through ontologies and semantics to their users.
This webinar explores the application of new tools and metrics to assess and promote the FAIR principles across ELIXIR Core Data Resources, highlighting the approach, findings, and lessons learned.
Toolkit
This third webinar in our Blockchain Education series explores the challenges and key considerations for implementing Blockchain technology in Healthcare, highlighting its potential to transform information exchange with greater security and trust.
In this webinar, we discuss how Elsevier is increasingly leveraging the FAIR Guiding Principles to improve its products and services to better serve the scientific community.
This webinar features UX specialists introducing User Experience and exploring how it can address design, trust, and ethical challenges in applying AI to life sciences.
In late 2018, a datathon led by the Pistoia Alliance, Elsevier, and partner charities rapidly identified four potential treatments for childhood chronic pancreatitis. This webinar explores the technologies that enabled this achievement.
Prof. John Overington, the CIO of the Medicines Discovery Catapult describes the AssayNet project and its very far reaching implications.
Hear our panel of experts from technology support providers and the biopharma industry share their views on the "Benefits and costs of FAIR Implementation for life science industry".
Developing new drugs is highly complex, but recent AI and machine learning research—such as work by Drs. Alex Tropsha and Ola Engkvist using deep reinforcement learning and neural networks—is helping address key challenges in drug design, which they will discuss in this webinar.
This project sort to demonstrate the value of blockchain technology as part of a decentralized digital identity solution for the Informed Consent process in clinical trials.
